ID   PLPP1_HUMAN             Reviewed;         284 AA.
AC   O14494; B7ZKN8; G3XA95; O60457; O60463; Q17RZ4;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   10-MAY-2017, entry version 151.
DE   RecName: Full=Phospholipid phosphatase 1 {ECO:0000312|HGNC:HGNC:9228};
DE            EC=3.1.3.4;
DE   AltName: Full=Lipid phosphate phosphohydrolase 1;
DE   AltName: Full=PAP2-alpha;
DE   AltName: Full=Phosphatidate phosphohydrolase type 2a;
DE   AltName: Full=Phosphatidic acid phosphatase 2a;
DE            Short=PAP-2a;
DE            Short=PAP2a;
GN   Name=PLPP1 {ECO:0000312|HGNC:HGNC:9228}; Synonyms=LPP1, PPAP2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RX   PubMed=9305923; DOI=10.1074/jbc.272.39.24572;
RA   Kai M., Wada I., Imai S., Sakane F., Kanoh H.;
RT   "Cloning and characterization of two human isozymes of Mg2+-
RT   independent phosphatidic acid phosphatase.";
RL   J. Biol. Chem. 272:24572-24578(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung;
RX   PubMed=9570154; DOI=10.1089/dna.1998.17.377;
RA   Leung D.W., Tompkins C.K., White T.;
RT   "Molecular cloning of two alternatively spliced forms of human
RT   phosphatidic acid phosphatase cDNAs that are differentially expressed
RT   in normal and tumor cells.";
RL   DNA Cell Biol. 17:377-385(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   PubMed=9468526; DOI=10.1074/jbc.273.8.4660;
RA   Ulrix W.E.J., Swinnen J., Heyns W., Verhoeven G.;
RT   "Identification of the phosphatidic acid phosphatase type 2a isozyme
RT   as an androgen-regulated gene in the human prostatic Adenocarcinoma
RT   cell line LNCaP.";
RL   J. Biol. Chem. 273:4660-4665(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RX   PubMed=9705349; DOI=10.1074/jbc.273.34.22059;
RA   Roberts R., Sciorra V.A., Morris A.J.;
RT   "Human type 2 phosphatidic acid phosphohydrolases. Substrate
RT   specificity of the type 2a, 2b, and 2c enzymes and cell surface
RT   activity of the 2a isoform.";
RL   J. Biol. Chem. 273:22059-22067(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION.
RX   PubMed=12909631; DOI=10.1074/jbc.M306709200;
RA   Smyth S.S., Sciorra V.A., Sigal Y.J., Pamulkar Z., Wang Z., Xu Y.,
RA   Prestwich G.D., Morris A.J.;
RT   "Lipid phosphate phosphatases regulate lysophosphatidic acid
RT   production and signaling in platelets: studies using chemical
RT   inhibitors of lipid phosphate phosphatase activity.";
RL   J. Biol. Chem. 278:43214-43223(2003).
CC   -!- FUNCTION: Broad-specificity phosphohydrolase that dephosphorylates
CC       exogenous bioactive glycerolipids and sphingolipids. Catalyzes the
CC       conversion of phosphatidic acid (PA) to diacylglycerol (DG).
CC       Pivotal regulator of lysophosphatidic acid (LPA) signaling in the
CC       cardiovascular system. Major enzyme responsible of
CC       dephosphorylating LPA in platelets, which terminates signaling
CC       actions of LPA. May control circulating, and possibly also
CC       regulate localized, LPA levels resulting from platelet activation.
CC       It has little activity towards ceramide-1-phosphate (C-1-P) and
CC       sphingosine-1-phosphate (S-1-P). The relative catalytic efficiency
CC       is LPA > PA > S-1-P > C-1-P. It's down-regulation may contribute
CC       to the development of colon adenocarcinoma.
CC       {ECO:0000269|PubMed:12909631}.
CC   -!- CATALYTIC ACTIVITY: A 1,2-diacylglycerol 3-phosphate + H(2)O = a
CC       1,2-diacyl-sn-glycerol + phosphate.
CC   -!- ENZYME REGULATION: Inhibited by sphingosine, zinc ions and
CC       propanolol. Not inhibited by N-ethylmaleimide treatment.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Alpha-1, hLPP1, PAP2-a1;
CC         IsoId=O14494-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha-2, hLPP1-a, PAP2-a2;
CC         IsoId=O14494-2; Sequence=VSP_009651;
CC         Note=Ref.2 (AAC16033) sequence is in conflict in position:
CC         55:V->A. Ref.2 (AAC16033) sequence is in conflict in position:
CC         56:T->A. Ref.2 (AAC16033) sequence is in conflict in position:
CC         69:I->V. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed with highest expression
CC       found in prostate. Isoform 1 is predominant in kidney, lung,
CC       placenta and liver. Isoform 2 is predominant in heart and
CC       pancreas. Found to be down-regulated in colon adenocarcinomas.
CC   -!- INDUCTION: By androgens.
CC   -!- PTM: N-glycosylated. Contains high-mannose oligosaccharides.
CC   -!- SIMILARITY: Belongs to the PA-phosphatase related phosphoesterase
CC       family. {ECO:0000305}.
CC   -!- CAUTION: PubMed:9305923 states that this phosphatase does not
CC       hydrolyze sphingosine 1-phosphate while PubMed:9705349 states that
CC       it does. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB000888; BAA22593.1; -; mRNA.
DR   EMBL; AF014402; AAC16032.1; -; mRNA.
DR   EMBL; AF014403; AAC16033.1; -; mRNA.
DR   EMBL; Y14436; CAC14588.1; -; mRNA.
DR   EMBL; AF017116; AAC32041.1; -; mRNA.
DR   EMBL; AC010480; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC025777; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471123; EAW54920.1; -; Genomic_DNA.
DR   EMBL; CH471123; EAW54922.1; -; Genomic_DNA.
DR   EMBL; BC039847; AAH39847.1; -; mRNA.
DR   EMBL; BC117133; AAI17134.1; -; mRNA.
DR   EMBL; BC143281; AAI43282.1; -; mRNA.
DR   CCDS; CCDS34159.1; -. [O14494-1]
DR   CCDS; CCDS34160.1; -. [O14494-2]
DR   RefSeq; NP_003702.2; NM_003711.3. [O14494-1]
DR   RefSeq; NP_795714.1; NM_176895.2. [O14494-2]
DR   UniGene; Hs.696231; -.
DR   ProteinModelPortal; O14494; -.
DR   BioGrid; 114169; 8.
DR   IntAct; O14494; 3.
DR   SwissLipids; SLP:000000160; -.
DR   DEPOD; O14494; -.
DR   iPTMnet; O14494; -.
DR   PhosphoSitePlus; O14494; -.
DR   EPD; O14494; -.
DR   MaxQB; O14494; -.
DR   PeptideAtlas; O14494; -.
DR   PRIDE; O14494; -.
DR   DNASU; 8611; -.
DR   Ensembl; ENST00000264775; ENSP00000264775; ENSG00000067113. [O14494-2]
DR   Ensembl; ENST00000307259; ENSP00000302229; ENSG00000067113. [O14494-1]
DR   GeneID; 8611; -.
DR   KEGG; hsa:8611; -.
DR   UCSC; uc003jpz.5; human. [O14494-1]
DR   CTD; 8611; -.
DR   DisGeNET; 8611; -.
DR   GeneCards; PLPP1; -.
DR   HGNC; HGNC:9228; PLPP1.
DR   HPA; CAB033331; -.
DR   HPA; HPA047815; -.
DR   MIM; 607124; gene.
DR   neXtProt; NX_O14494; -.
DR   OpenTargets; ENSG00000067113; -.
DR   PharmGKB; PA33552; -.
DR   GeneTree; ENSGT00620000087654; -.
DR   HOGENOM; HOG000041307; -.
DR   HOVERGEN; HBG002048; -.
DR   InParanoid; O14494; -.
DR   KO; K01080; -.
DR   OMA; RGLFCND; -.
DR   PhylomeDB; O14494; -.
DR   TreeFam; TF316040; -.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   ChiTaRS; PPAP2A; human.
DR   GeneWiki; PPAP2A; -.
DR   GenomeRNAi; 8611; -.
DR   PRO; PR:O14494; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000067113; -.
DR   CleanEx; HS_PPAP2A; -.
DR   ExpressionAtlas; O14494; baseline and differential.
DR   Genevisible; O14494; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042577; F:lipid phosphatase activity; IBA:GO_Central.
DR   GO; GO:0008195; F:phosphatidate phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0042392; F:sphingosine-1-phosphate phosphatase activity; TAS:Reactome.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0008354; P:germ cell migration; TAS:ProtInc.
DR   GO; GO:0030518; P:intracellular steroid hormone receptor signaling pathway; TAS:UniProtKB.
DR   GO; GO:0006629; P:lipid metabolic process; NAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; NAS:UniProtKB.
DR   GO; GO:0046839; P:phospholipid dephosphorylation; TAS:UniProtKB.
DR   GO; GO:0006644; P:phospholipid metabolic process; IBA:GO_Central.
DR   GO; GO:0006470; P:protein dephosphorylation; IEA:Ensembl.
DR   GO; GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; TAS:UniProtKB.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; NAS:UniProtKB.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   Gene3D; 1.20.144.10; -; 1.
DR   InterPro; IPR028670; LPP1.
DR   InterPro; IPR000326; P_Acid_Pase_2/haloperoxidase.
DR   PANTHER; PTHR10165:SF112; PTHR10165:SF112; 1.
DR   Pfam; PF01569; PAP2; 1.
DR   SMART; SM00014; acidPPc; 1.
DR   SUPFAM; SSF48317; SSF48317; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Complete proteome; Glycoprotein;
KW   Hydrolase; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    284       Phospholipid phosphatase 1.
FT                                /FTId=PRO_0000220905.
FT   TOPO_DOM      1      6       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      7     27       Helical. {ECO:0000255}.
FT   TOPO_DOM     28     53       Extracellular. {ECO:0000255}.
FT   TRANSMEM     54     74       Helical. {ECO:0000255}.
FT   TOPO_DOM     75     94       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     95    115       Helical. {ECO:0000255}.
FT   TOPO_DOM    116    164       Extracellular. {ECO:0000255}.
FT   TRANSMEM    165    185       Helical. {ECO:0000255}.
FT   TOPO_DOM    186    199       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    200    220       Helical. {ECO:0000255}.
FT   TOPO_DOM    221    229       Extracellular. {ECO:0000255}.
FT   TRANSMEM    230    250       Helical. {ECO:0000255}.
FT   TOPO_DOM    251    284       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD    142    142       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ      21     70       GLPFAILTSRHTPFQRGVFCNDESIKYPYKEDTIPYALLGG
FT                                IIIPFSIIV -> SMPMAVLKLGQIYPFQRGFFCKDNSINY
FT                                PYHDSTVTSTVLILVGVGLPISS (in isoform 2).
FT                                {ECO:0000303|PubMed:9570154}.
FT                                /FTId=VSP_009651.
FT   CONFLICT     27     27       L -> FTSRHI (in Ref. 4; AAC32041).
FT                                {ECO:0000305}.
FT   CONFLICT     91     91       R -> S (in Ref. 2; AAC16033).
FT                                {ECO:0000305}.
SQ   SEQUENCE   284 AA;  32156 MW;  FC2F00617EE07EB3 CRC64;
     MFDKTRLPYV ALDVLCVLLA GLPFAILTSR HTPFQRGVFC NDESIKYPYK EDTIPYALLG
     GIIIPFSIIV IILGETLSVY CNLLHSNSFI RNNYIATIYK AIGTFLFGAA ASQSLTDIAK
     YSIGRLRPHF LDVCDPDWSK INCSDGYIEY YICRGNAERV KEGRLSFYSG HSSFSMYCML
     FVALYLQARM KGDWARLLRP TLQFGLVAVS IYVGLSRVSD YKHHWSDVLT GLIQGALVAI
     LVAVYVSDFF KERTSFKERK EEDSHTTLHE TPTTGNHYPS NHQP
//
